Log In
BCIQ
Print this Print this
 

ATN-658

  Manage Alerts
Collapse Summary General Information
Company Tactic Pharma LLC
DescriptionHumanized mAb to the urokinase plasminogen activator receptor (uPAR).
Molecular Target Plasminogen activator urokinase receptor (PLAUR) (uPAR) (suPAR)
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPreclinical
Standard Indication Cancer (unspecified)
Indication DetailsTreat cancer
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today